Creative Planning - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 228 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$45,507
-45.2%
51,362
-2.5%
0.00%
Q3 2022$83,000
-12.6%
52,683
+11.3%
0.00%
Q2 2022$95,000
+5.6%
47,318
+23.1%
0.00%
Q1 2022$90,000
-23.7%
38,438
+148.9%
0.00%
Q3 2021$118,000
-46.4%
15,443
-32.0%
0.00%
Q2 2021$220,000
-64.3%
22,704
-69.6%
0.00%
-100.0%
Q1 2021$617,000
+12.4%
74,578
-7.2%
0.00%0.0%
Q4 2020$549,000
-20.1%
80,380
+30.5%
0.00%
-50.0%
Q3 2020$687,000
+131.3%
61,617
+30.5%
0.00%
+100.0%
Q2 2020$297,000
+1463.2%
47,225
+366.2%
0.00%
Q1 2020$19,000
-50.0%
10,130
-36.7%
0.00%
Q4 2018$38,000
-45.7%
16,0000.0%0.00%
Q3 2018$70,000
-39.1%
16,0000.0%0.00%
Q2 2018$115,000
+9.5%
16,000
-21.4%
0.00%
Q1 2018$105,000
+56.7%
20,350
+15.6%
0.00%
Q4 2017$67,000
+52.3%
17,600
-31.3%
0.00%
Q3 2017$44,000
-13.7%
25,602
+0.0%
0.00%
Q2 2017$51,000
-49.5%
25,6000.0%0.00%
-100.0%
Q1 2017$101,000
-27.9%
25,600
-10.5%
0.00%0.0%
Q4 2016$140,000
-37.8%
28,600
-1.5%
0.00%0.0%
Q3 2016$225,000
+40.6%
29,025
+1.5%
0.00%0.0%
Q2 2016$160,000
+3.9%
28,6000.0%0.00%0.0%
Q1 2016$154,000
-38.2%
28,6000.0%0.00%
-50.0%
Q4 2015$249,000
+538.5%
28,600
+368.9%
0.00%
Q3 2015$39,000
+77.3%
6,100
+221.1%
0.00%
Q1 2015$22,000
+15.8%
1,9000.0%0.00%
Q4 2014$19,000
+171.4%
1,900
+18.8%
0.00%
Q3 2014$7,0001,6000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders